letterNew England Journal of MedicineSep 17, 2025Closed access

In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus

QWQian WangZXZe Xiu XiaoXZXu ZhengGWGuihong WangLYLinlin Yang

University of Science and Technology of China · Beike Biotechnology (China) · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

85
total citations
FWCI
67.05
Percentile
100%
References
6
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • Refractory (planetary science)
  • In vivo
  • CD19
  • Lupus erythematosus
  • Autoimmune disease
  • Connective tissue disease
No related works found for this paper.

Funding